Skip to Main Content
  • About Us
  • People
  • Capabilities
  • News & Insights
  • Events

Dobbs Decision Resource Center: Practical Guidance

On June 24, 2022, the Supreme Court of the United States issued its decision in the case, Dobbs, State Health Officer of the Mississippi Department of Health, et al. v. Jackson Women’s Health Organization et al., 597 U.S. 215 (2022), which concluded that the United States Constitution does not confer a right to abortion.  The decision has the effect of overruling the landmark cases, Roe v. Wade, 410 U.S. 113 (1973), and Planned Parenthood of Southeastern Pa. v. Casey, 505 U.S. 833 (1992), and, as a result, now leaves the issue of abortion to each individual state’s rulemaking.

This resource center provides a summary of the Dobbs decision and analyses of some of the practical impacts of this landmark case on healthcare, employee benefits and employment law, as well as First Amendment considerations and other practical ramifications. We will update this page as legislative developments and administrative guidance warrant.  If you have any questions about the Dobbs decision and its impact on your organization, please contact any of the authors of the articles listed in this Resource Center.

Latest Updates and Analyses of Dobbs: Considerations for Healthcare Providers and Insurers

Idaho Federal Judge Warns of Conflicts Between Restrictive Abortion Laws and EMTALA - April 2, 2025
Authored by: Joan Feldman and Chelsea McCallum

Two Federal Courts Issue Injunctions Temporarily Blocking Trump's Executive Order Restricting Access to Gender-Affirming Care - February 17, 2025
Authored by: Joan Feldman and Chelsea McCallum

U.S. Supreme Court To Decide Whether Medicaid Recipients Have Right To Choose Provider in Ongoing Court Battle To Restrict Funding To Abortion Clinics - December 30, 2024
Authored by: Joan Feldman and Chelsea McCallum

HIPAA Rule Strengthening the Privacy of Reproductive Health Care Services Takes Effect December 23rd - December 9, 2024
Authored by: Joan Feldman and Marc Lombardi

U.S. Supreme Court Upholds HHS’ Decision to Withhold Federal Grants as a Consequence of Oklahoma’s Failure to Comply with Federal Requirement for Abortion Counseling - September 5, 2024
Authored by: Joan Feldman and Benjamin Sharpe

Ohio Injunction Issued for Abortion Statutes At Odds with State Constitutional Reproductive Rights - August 28, 2024
Authored by: Joan Feldman and Benjamin Sharpe

Kansas Supreme Court Reaffirms Fundamental Right to Abortion - July 9, 2024
Authored by: Joan Feldman and Benjamin Sharpe

Emergency Abortion Rights Temporarily Restored in Idaho by Supreme Court - June 28, 2024
Authored by: Joan Feldman and Benjamin Sharpe

Supreme Court Unanimously Strikes Down Legal Challenges to Abortion Drug - June 14, 2024
Authored by: Joan Feldman and Benjamin Sharpe

Arizona Supreme Court Lifts Injunction on Near-Total Abortion Ban - April 12, 2024
Authored by: Joan Feldman and Benjamin Sharpe

Florida Supreme Court Issues Divergent Opinions Impacting Abortion Rights in Florida - April 2, 2024
Authored by: Joan Feldman

United States Court of Appeals for the Fifth Circuit Issues Another Restriction on Reproductive Rights and Federal Agency Action - January 8, 2024
Authored by: Joan Feldman

Recent Developments Under Texas' Abortion Law - December 15, 2023
Authored by: Joan Feldman and Sarah Elkins

Danco Laboratories and the Department of Justice File Briefs As Battle Over Abortion Drug Continues in U.S. Supreme Court - November 13, 2023
Authored by: Joan Feldman and Ian Leon

Abortion Opponents Seek Full Supreme Court Review of Fifth Circuit Holding - October 23, 2023
Authored by: Joan Feldman and Ian Leon

Petition for Writ of Certiorari Filed Urging Justices to Hear Case on Abortion Pill Restrictions - September 20, 2023
Authored by: Joan Feldman and Ian Leon

Fifth Circuit Court of Appeals Upholds FDA’s 2000 Abortion Pill Approval and Reinstates 2011 More Restrictive Rules Regarding Dispensing of the Drug - August 17, 2023
Authored by: Joan Feldman

Abortion Bans Temporarily Blocked in Several States - June 26, 2023
Authored by: Joan Feldman

Oklahoma Supreme Court Rules Two State Anti-Abortion Laws Unconstitutional - June 5, 2023
Authored by: Joan Feldman

South Carolina's Second Attempt to Restrict Abortion - May 30, 2023
Authored by: Joan Feldman

North Carolina Bans Abortions After 12 Weeks - May 19, 2023
Authored by: Matthew Gibbons

South Carolina Legislature Advances 6-Week Abortion Ban - May 19, 2023
Authored by: Matthew Gibbons

Utah Judge Strikes Law Banning Abortion Clinics - May 3, 2023
Authored by: Joan Feldman

Three Recent Developments in Ongoing Court Battles Over Abortion Rights Waged at State and Federal Levels - April 25, 2023
Authored by: Joan Feldman and Matthew Gibbons

U.S. Supreme Court Removes Restrictions on Abortion Drug Pending Appeal - April 24, 2023
On Friday, April 21, 2023, the United States Supreme Court issued an order stating that “[T]he April 7, 2023 order of the United States District Court for the Northern District of Texas, case No. 2:22–cv–223, is stayed pending disposition of the appeal in the United States Court of Appeals for the Fifth Circuit and disposition of a petition for a writ of certiorari, if such a writ is timely sought. Should certiorari be denied, this stay shall terminate automatically. In the event certiorari is granted, the stay shall terminate upon the sending down of the judgment of this Court.”  Justices Thomas and Alito dissented.  

As a result of the stay any restrictions placed upon the FDA’s approval of mifepristone are no longer in effect and the medication continues to be available by mail in accordance with the state laws. It is expected that appeal will ultimately be considered by the Court through certiorari.

U.S. Supreme Court Further Extends Stay - April 19, 2023
On Wednesday, just hours before a midnight deadline previously set by Justice Samuel Alito, the Supreme Court further extended a temporary stay to maintain the Food and Drug Administration's approval of the abortion pill mifepristone amid ongoing litigation. On Friday, Justice Alito granted a five day stay of the Texas Order by Judge Kacsmaryk, which put distribution of mifepristone on hold pending resolution of the legal challenges with respect to the FDA’s approval of the drug. The administrative stay will now be in place until 11:59 p.m. on Friday, April 21, 2023.

U.S. Supreme Court Grants Stay In Court Battle Over Abortion Drug Mifepristone  - April 14, 2023
Judge Alito of the U.S. Supreme Court temporarily extends access to mifepristone, issuing a stay on Judge Kacsmaryk’s April 7, 2023 ruling until 11:59 p.m. April 19 in response to the U.S. Solicitor General’s Application for a stay.  The Plaintiffs have until Tuesday April 18, 2023 12:00 p.m. to submit any response to the Solicitor General’s Application for a stay.  At this time, women can continue to receive mifepristone by mail.

Federal Government Files Application to Stay Texas Order Regarding Abortion Drug With U.S. Supreme Court - April 14, 2023
The U.S. Solicitor General on behalf of the FDA, et al., filed with the United States Supreme Court an Application to stay the order in full entered by the United States District Court for the Northern District of Texas and for an administrative stay to preserve the status quo while the Court considers the application. See April 7th Decision.

HHS Proposes Revisions to HIPAA Privacy Rule Addressing Concerns about Reproductive Health Care - April 14, 2023
Authored by: Marc Lombardi

Fifth Circuit Court of Appeals Issues Ruling in Abortion Drug Court Battle - April 13, 2023
Authored by: Joan Feldman

Two Federal Courts Take Contrary Legal Positions on Medication Abortions - April 10, 2023
Authored by: Joan Feldman

Wyoming To Ban Abortion Medication - March 21, 2023
Authored by: Joan Feldman

Constitutional Right to Abortion in North Dakota - March 17, 2023
Authored by: Joan Feldman and Matthew Gibbons

In Certain States Retail Pharmacies Face Difficult Balancing Act Relating to the Sale of Mifepristone - March 10, 2023
Authored by: Joan Feldman and Matthew Gibbons

State Attorneys General Choose Sides in Legal Battle Over Abortion Drug Mifepristone - February 13, 2023
Authored by: Joan Feldman 

Twenty Attorneys General Challenge the Mailing of Abortion Medication - February 7, 2023
Authored by: Joan Feldman 

New Illinois Statute Seeks to Protect Providers and Patients Seeking Abortions and Gender-Affirming Care in that State - January 18, 2023
Authored by: Matthew Gibbons

Constitutional Right to Abortion in South Carolina - January 5, 2023
Authored by: Joan Feldman

Mailing of Abortion Medication - January 4, 2023
Authored by: Joan Feldman

FDA and Medical Abortions - January 3, 2023
Authored by: Joan Feldman

Judge Finds Plaintiff Lacks Standing to Enforce Texas Heartbeat Act - December 12, 2022
Authored by: Joan Feldman and Matthew Gibbons

Sixth Circuit Considers Ten-Foot Buffer Zone - December 12, 2022
Authored by: Joan Feldman and Matthew Gibbons

Revised HHS Guidance for Unaccompanied Children Needing Reproductive Healthcare - November 17, 2022
Authored by: Joan Feldman and Kelsey Scarlett

State Court Prohibits Enforcement of Georgia's 6-Week Abortion Ban - November 16, 2022
Authored by: Joan Feldman and Matthew Gibbons

Election Day Brings the Potential to Alter the Reproductive Rights Landscape Across the Country - November 10, 2022
Authored by: Joan Feldman and Kelsey Scarlett

From 1985 to Now: Revisiting Abortion Funding in Pennsylvania’s Supreme Court - October 31, 2022
Authored by: Joan Feldman and Kelsey Scarlett

The Impact of Dobbs on Campus Health Clinics Operated by Colleges and Universities - October 25, 2022
Authored by: Joan Feldman, Julie P. Jaquays and Kelsey Scarlett 

Ohio Appeals Judge's Renewed Order Blocking Abortion Ban - October 14, 2022
Authored by: Joan Feldman

Supreme Court Rejects Dobbs Follow-Up Case re Fetal Personhood - October 11, 2022

Authored by: Joan Feldman 

Indiana’s Week-Old Abortion Ban Enjoined by State Judge - September 22, 2022
Authored by: Joan Feldman

Ohio's Abortion Ban Temporarily On Hold - September 15, 2022, Updated September 21
Authored by:
 Joan Feldman

Two Months Post-'Dobbs' What Healthcare Providers Need to Know
A JD Supra Exclusive Q&A with Joan Feldman 

Preliminary Injunction Issued in Idaho to Block State Ban on Abortions - August 25, 2022
Authored by: Joan Feldman 

Connecticut's First-in-the-Nation Reproductive Health Care Law and the State's Commitment to Patient Access and Privacy - August 12, 2022
Authored by: Joan Feldman and Kelsey Scarlett

President Biden Issues Second Executive Order Relating to Reproductive Healthcare Services - August 4, 2022
Authored by: Joan Feldman and Matthew Gibbons

U.S. Department of Justice Files Lawsuit to Prevent Idaho from Enforcing its Near-Absolute State Abortion Ban - August 3, 2022
Authored by: Joan Feldman and Julie P. Jaquays

House Bills, Georgia's Abortion Restrictions, and Privacy Concerns Post-Dobbs - July 21, 2022
Authored by: Joan Feldman and Matthew Gibbons

House Passes Two Bills Seeking to Create and Comprehensively Protect a Statutory Right to Abortion - July 18, 2022
Authored by: Joan Feldman and Matthew Gibbons

Texas Challenges HHS Guidance Clarifying that Emergency Medical Care under the EMTALA Includes Abortions - July 15, 2022
Authored by: Joan Feldman and Julie P. Jaquays

OCR Provides Guidance to Pharmacies Regarding Ensuring Access to Reproductive Health Care Services In the Wake of Dobbs - July 14, 2022
Authored by: Joan Feldman and Vincenzo Carannante

EMTALA Preempts State Law Abortion Bans - July 12, 2022
Authored by: Joan Feldman

President Biden Issues Executive Order Protecting Access to Reproductive Healthcare Services - July 8, 2022
Authored by: Joan Feldman 

OCR Issues HIPAA Guidance Post Dobbs- June 29, 2022
Authored by: Joan Feldman and Marc Lombardi

The Dobbs Decision: Practical Implications for Health Care - June 27, 2022
Authored by: Joan Feldman

Initial Analysis

The U.S. Supreme Court's Nullification of the Constitutional Right to Abortion: Practical Considerations - June 27, 2022
Authored by: Marc Esterman, Joan Feldman and Kelly Hathorn

Danco Laboratories and the Department of Justice File Briefs As Battle Over Abortion Drug Continues in U.S. Supreme Court - November 13, 2023
Authored by: Joan Feldman and Ian Leon

Abortion Opponents Seek Full Supreme Court Review of Fifth Circuit Holding - October 23, 2023
Authored by: Joan Feldman and Ian Leon

Petition for Writ of Certiorari Filed Urging Justices to Hear Case on Abortion Pill Restrictions - September 20, 2023
Authored by: Joan Feldman and Ian Leon

Fifth Circuit Court of Appeals Upholds FDA’s 2000 Abortion Pill Approval and Reinstates 2011 More Restrictive Rules Regarding Dispensing of the Drug - August 17, 2023
Authored by: Joan Feldman

Abortion Bans Temporarily Blocked in Several States - June 26, 2023
Authored by: Joan Feldman

Oklahoma Supreme Court Rules Two State Anti-Abortion Laws Unconstitutional - June 5, 2023
Authored by: Joan Feldman

South Carolina's Second Attempt to Restrict Abortion - May 30, 2023
Authored by: Joan Feldman

North Carolina Bans Abortions After 12 Weeks - May 19, 2023
Authored by: Matthew Gibbons

South Carolina Legislature Advances 6-Week Abortion Ban - May 19, 2023
Authored by: Matthew Gibbons

Utah Judge Strikes Law Banning Abortion Clinics - May 3, 2023
Authored by: Joan Feldman

Three Recent Developments in Ongoing Court Battles Over Abortion Rights Waged at State and Federal Levels - April 25, 2023
Authored by: Joan Feldman and Matthew Gibbons

U.S. Supreme Court Removes Restrictions on Abortion Drug Pending Appeal - April 24, 2023
On Friday, April 21, 2023, the United States Supreme Court issued an order stating that “[T]he April 7, 2023 order of the United States District Court for the Northern District of Texas, case No. 2:22–cv–223, is stayed pending disposition of the appeal in the United States Court of Appeals for the Fifth Circuit and disposition of a petition for a writ of certiorari, if such a writ is timely sought. Should certiorari be denied, this stay shall terminate automatically. In the event certiorari is granted, the stay shall terminate upon the sending down of the judgment of this Court.”  Justices Thomas and Alito dissented.  

As a result of the stay any restrictions placed upon the FDA’s approval of mifepristone are no longer in effect and the medication continues to be available by mail in accordance with the state laws. It is expected that appeal will ultimately be considered by the Court through certiorari.

U.S. Supreme Court Further Extends Stay - April 19, 2023
On Wednesday, just hours before a midnight deadline previously set by Justice Samuel Alito, the Supreme Court further extended a temporary stay to maintain the Food and Drug Administration's approval of the abortion pill mifepristone amid ongoing litigation. On Friday, Justice Alito granted a five day stay of the Texas Order by Judge Kacsmaryk, which put distribution of mifepristone on hold pending resolution of the legal challenges with respect to the FDA’s approval of the drug. The administrative stay will now be in place until 11:59 p.m. on Friday, April 21, 2023.

U.S. Supreme Court Grants Stay In Court Battle Over Abortion Drug Mifepristone  - April 14, 2023
Judge Alito of the U.S. Supreme Court temporarily extends access to mifepristone, issuing a stay on Judge Kacsmaryk’s April 7, 2023 ruling until 11:59 p.m. April 19 in response to the U.S. Solicitor General’s Application for a stay.  The Plaintiffs have until Tuesday April 18, 2023 12:00 p.m. to submit any response to the Solicitor General’s Application for a stay.  At this time, women can continue to receive mifepristone by mail.

Federal Government Files Application to Stay Texas Order Regarding Abortion Drug With U.S. Supreme Court - April 14, 2023
The U.S. Solicitor General on behalf of the FDA, et al., filed with the United States Supreme Court an Application to stay the order in full entered by the United States District Court for the Northern District of Texas and for an administrative stay to preserve the status quo while the Court considers the application. See April 7th Decision.

HHS Proposes Revisions to HIPAA Privacy Rule Addressing Concerns about Reproductive Health Care - April 14, 2023
Authored by: Marc Lombardi

Fifth Circuit Court of Appeals Issues Ruling in Abortion Drug Court Battle - April 13, 2023
Authored by: Joan Feldman

Two Federal Courts Take Contrary Legal Positions on Medication Abortions - April 10, 2023
Authored by: Joan Feldman

Wyoming To Ban Abortion Medication - March 21, 2023
Authored by: Joan Feldman

Constitutional Right to Abortion in North Dakota - March 17, 2023
Authored by: Joan Feldman and Matthew Gibbons

In Certain States Retail Pharmacies Face Difficult Balancing Act Relating to the Sale of Mifepristone - March 10, 2023
Authored by: Joan Feldman and Matthew Gibbons

State Attorneys General Choose Sides in Legal Battle Over Abortion Drug Mifepristone - February 13, 2023
Authored by: Joan Feldman 

Twenty Attorneys General Challenge the Mailing of Abortion Medication - February 7, 2023
Authored by: Joan Feldman 

New Illinois Statute Seeks to Protect Providers and Patients Seeking Abortions and Gender-Affirming Care in that State - January 18, 2023
Authored by: Matthew Gibbons

Constitutional Right to Abortion in South Carolina - January 5, 2023
Authored by: Joan Feldman

Mailing of Abortion Medication - January 4, 2023
Authored by: Joan Feldman

FDA and Medical Abortions - January 3, 2023
Authored by: Joan Feldman

Judge Finds Plaintiff Lacks Standing to Enforce Texas Heartbeat Act - December 12, 2022
Authored by: Joan Feldman and Matthew Gibbons

Sixth Circuit Considers Ten-Foot Buffer Zone - December 12, 2022
Authored by: Joan Feldman and Matthew Gibbons

Revised HHS Guidance for Unaccompanied Children Needing Reproductive Healthcare - November 17, 2022
Authored by: Joan Feldman and Kelsey Scarlett

State Court Prohibits Enforcement of Georgia's 6-Week Abortion Ban - November 16, 2022
Authored by: Joan Feldman and Matthew Gibbons

Election Day Brings the Potential to Alter the Reproductive Rights Landscape Across the Country - November 10, 2022
Authored by: Joan Feldman and Kelsey Scarlett

From 1985 to Now: Revisiting Abortion Funding in Pennsylvania’s Supreme Court - October 31, 2022
Authored by: Joan Feldman and Kelsey Scarlett

The Impact of Dobbs on Campus Health Clinics Operated by Colleges and Universities - October 25, 2022
Authored by: Joan Feldman, Julie P. Jaquays and Kelsey Scarlett 

Ohio Appeals Judge's Renewed Order Blocking Abortion Ban - October 14, 2022
Authored by: Joan Feldman

Supreme Court Rejects Dobbs Follow-Up Case re Fetal Personhood - October 11, 2022

Authored by: Joan Feldman 

Indiana’s Week-Old Abortion Ban Enjoined by State Judge - September 22, 2022
Authored by: Joan Feldman

Ohio's Abortion Ban Temporarily On Hold - September 15, 2022, Updated September 21
Authored by:
 Joan Feldman

Two Months Post-'Dobbs' What Healthcare Providers Need to Know
A JD Supra Exclusive Q&A with Joan Feldman 

Preliminary Injunction Issued in Idaho to Block State Ban on Abortions - August 25, 2022
Authored by: Joan Feldman 

Connecticut's First-in-the-Nation Reproductive Health Care Law and the State's Commitment to Patient Access and Privacy - August 12, 2022
Authored by: Joan Feldman and Kelsey Scarlett

President Biden Issues Second Executive Order Relating to Reproductive Healthcare Services - August 4, 2022
Authored by: Joan Feldman and Matthew Gibbons

U.S. Department of Justice Files Lawsuit to Prevent Idaho from Enforcing its Near-Absolute State Abortion Ban - August 3, 2022
Authored by: Joan Feldman and Julie P. Jaquays

House Bills, Georgia's Abortion Restrictions, and Privacy Concerns Post-Dobbs - July 21, 2022
Authored by: Joan Feldman and Matthew Gibbons

House Passes Two Bills Seeking to Create and Comprehensively Protect a Statutory Right to Abortion - July 18, 2022
Authored by: Joan Feldman and Matthew Gibbons

Texas Challenges HHS Guidance Clarifying that Emergency Medical Care under the EMTALA Includes Abortions - July 15, 2022
Authored by: Joan Feldman and Julie P. Jaquays

OCR Provides Guidance to Pharmacies Regarding Ensuring Access to Reproductive Health Care Services In the Wake of Dobbs - July 14, 2022
Authored by: Joan Feldman and Vincenzo Carannante

EMTALA Preempts State Law Abortion Bans - July 12, 2022
Authored by: Joan Feldman

President Biden Issues Executive Order Protecting Access to Reproductive Healthcare Services - July 8, 2022
Authored by: Joan Feldman 

OCR Issues HIPAA Guidance Post Dobbs- June 29, 2022
Authored by: Joan Feldman and Marc Lombardi

The Dobbs Decision: Practical Implications for Health Care - June 27, 2022
Authored by: Joan Feldman

Initial Analysis

The U.S. Supreme Court's Nullification of the Constitutional Right to Abortion: Practical Considerations - June 27, 2022
Authored by: Marc Esterman, Joan Feldman and Kelly Hathorn

Related Events and Speaking Engagements

November 17, 2022
The Future of Reproductive Healthcare: A Post-Dobbs Discussion
UConn School of Law

Employee Benefits Considerations

The Dobbs Decision: Initial Implications for Employee Benefits - June 27, 2022
Authored by: Kelly Hathorn

Considerations for Employers

The Dobbs Decision: Initial Implications for Employers - June 27, 2022
Authored by: Peter Murphy

Dobbs and the Impact of the Court's Decision for Employers - June 27, 2022
Authored by Dan Schwartz

First Amendment Considerations

The Dobbs Decision: First Amendment Considerations - June 27, 2022
Authored by: Tom Mooney

Keep in Touch

Stay current with our latest insights

Manage Subscriptions
  • Lawyers
  • Capabilities
  • Events
  • Diversity, Equity and Inclusion
  • Pro Bono and Community
  • Blogs and Resource Centers
  • Insights
  • Podcasts
  • Dobbs Decision Resource Center
  • About Us
  • Careers
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility Statement

© Shipman & Goodwin LLP™ 2025. All Rights Reserved